The research project Screen4Care aims to tackle the major hurdle for rare disease patients – the lengthy and convoluted diagn ... osis journey – via an innovative research approach based on two central pillars: genetic newborn screening and artificial intelligence (AI)-based tools. Screen4Care has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No. 101034427. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. www.imi.europa.eu The communication here reflects the author's view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein. read more